focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 490.00
Bid: 490.00
Ask: 491.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.204%)
Open: 485.00
High: 495.00
Low: 485.00
Prev. Close: 490.00
TET Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

12 Apr 2021 07:00

RNS Number : 0398V
Treatt PLC
12 April 2021
 

12 April 2021

 

TREATT PLC

("Treatt" or "the Group")

 

Half Year Trading Update

 

Momentum continues with strong growth in revenue and margins

 

Treatt, the manufacturer and supplier of a diverse and sustainable portfolio of natural extracts and ingredients for the beverage, flavour and fragrance industries, today publishes a trading update for the half year ended 31 March 2021 (the "Period").

 

Highlights

 

· Strong performance across all categories with revenue expected to grow by 14% to approximately £60.8m (H1 2020: £53.6m).

· Growth particularly strong in tea, health & wellness and fruit & vegetables categories meeting growing global consumer demand for healthier living.

· Gross margin improvements reflect the growth of the above categories and the transition into more sophisticated, solution-driven products in citrus.

· New, state-of-the-art, UK headquarters opening April 2021 with colleagues beginning to transition on a phased basis, which, along with the recently expanded US facility, ensures the Group is well-positioned for future growth.

· Trading in line with the Board's revised expectations as announced in January 2021.

 

Trading performance

 

Following the trading update announced in January 2021, the Board is pleased to confirm that momentum has continued across the business. Expected revenue growth for the half year of 14% (16% in constant currency) has been driven by the Group's fast-growing and higher margin categories of tea, health & wellness and fruit & vegetables. These categories in particular meet the growing demand from consumers for more natural, clean-label and 'better-for-you' beverages and are driving pipeline growth and, in turn, our financial performance.

 

During the Period the Group has won significant new business across a wide range of beverage and flavour applications including the fast-growing alcoholic seltzer market which continues to expand rapidly in the US and begins to gain traction globally. Revenue growth has been achieved through direct sales to global and local brand owners as well as indirectly through the flavour and fragrance industry, demonstrating the strength of the Group's business model.

 

Citrus revenue has returned to modest growth, following a decline in FY20, and margins improved materially in the Period as the Group's prior investment in more sophisticated extraction technologies resulted in the launch of more value-add ingredients. In addition, raw material prices for orange oil, which fell significantly in 2019, have returned to more normalised levels.

 

The Group continues to grow its synthetic aroma business. This category, which includes important flavour ingredients for meat alternative protein flavours and snack foods, performed well with revenue up significantly compared with the prior year. Herbs, spices & florals, which include an extensive range of manufactured and traded essential oils and extracts, saw revenues fall in the Period due to reduced demand caused by Covid-19.

 

Work on our new UK facility continues apace and we are now a significant way through the operational fit out. We will begin transitioning colleagues across in late April 2021 and will start the commissioning of the new plant and machinery later this calendar year as planned, to enable production to relocate. We believe this site, along with our recently expanded US facility, will provide Treatt with a much stronger platform to support its growth ambitions.

 

With the UK relocation nearing completion, net debt at the end of the Period was £5.1m with total bank facilities of £21.2m remaining undrawn.

 

Whilst the Group's hedging strategy is intended to mitigate the impact of exchange rate movements, there can be material effects in the short term. During the Period there was a strengthening of Sterling against the US Dollar and, as a result, the Board anticipates a net positive FX impact on the results for the Period of approximately £0.4m.

 

Outlook

 

As reported in our January 2021 trading update, the financial year began strongly in terms of both revenue and margins; this momentum has continued throughout H1, with trading in line with the Board's revised expectations. April 2021 is on track to be another strong month for the Group and performance in the second half should be bolstered by increased demand for the Group's diverse range of natural extracts as hospitality venues, including sports stadia, gradually open.

 

It is currently expected that Treatt's half year results for the six months ended 31 March 2021 will be announced on 11 May 2021, when a further update will be provided based on performance to 30 April 2021 and the outlook for the rest of the year.

 

Daemmon Reeve, CEO, commented:

 

"Performance across the Group continues to be very strong despite the ongoing global Covid-19 related restrictions. These measures continue to impact our customers in global hospitality industries and whilst the outlook is promising, we are taking a conservative approach and will assess how our order book progresses in the coming weeks and months. The success we have had in diversifying the Group's flavour and fragrance expertise across a wide range of categories has helped our resilience over the Period.

 

Our strategy is driven by an obsession with offering solutions that are of clear relevance to our customer base, providing differentiated ingredients that align with consumer trends in growing markets. Our effectiveness in developing these relationships continues to shine through and the execution is testament to the skill and endeavour of our colleagues together with the culture across the Group."

 

 

Enquiries:

Treatt plc +44 (0)1284 702500

Daemmon Reeve Chief Executive Officer

Richard Hope Chief Financial Officer

 

Joint Brokers

Investec Bank Plc +44 (0)20 7597 5970

Patrick Robb

David Anderson

Alex Wright

 

Peel Hunt LLP +44 (0) 20 7418 8900

George Sellar

Andrew Clark

Will Bell

 

Financial PR

MHP Communications +44 (0) 20 3128 8789

Tim Rowntree

Simon Hockridge

Catherine Chapman

 

About the Group

Treatt is a global, independent manufacturer and supplier of a diverse and sustainable portfolio of natural extracts and ingredients for the flavour, fragrance and multinational consumer product industries, particularly in the beverage sector. Renowned for its technical expertise and knowledge of ingredients, their origins and market conditions, Treatt is recognised as a leader in its field.

 

The Group employs over 300 staff in Europe, North America and Asia and has manufacturing facilities in the UK and US. Its international footprint enables the Group to deliver powerful and integrated solutions for the food, beverage and fragrance industries across the globe.

 

 

For further information about the Group, visit www.treatt.com.

 

 

CAUTIONARY STATEMENT ABOUT FORWARD-LOOKING STATEMENTS

This announcement contains forward-looking statements that are subject to risk factors associated with, among other things, the economic and business circumstances occurring from time to time in the countries, sectors and markets in which the Group operates. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a wide range of variables which could cause actual results to differ materially from those currently anticipated. No assurances can be given that the forward-looking statements in this announcement will be realised. The forward-looking statements reflect the knowledge and information available at the date of preparation of this announcement and the Group undertakes no obligation to update these forward-looking statements. Nothing in this announcement should be construed as a profit forecast.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFVESSIAIIL
Date   Source Headline
27th Nov 20187:00 amRNSFinal Results
16th Nov 201812:07 pmRNSSecond Price Monitoring Extn
16th Nov 201812:02 pmRNSPrice Monitoring Extension
14th Nov 201812:13 pmRNSHolding(s) in Company
13th Nov 20184:35 pmRNSPrice Monitoring Extension
9th Nov 20184:40 pmRNSSecond Price Monitoring Extn
9th Nov 20184:35 pmRNSPrice Monitoring Extension
6th Nov 20183:44 pmRNSHolding(s) in Company
16th Oct 20189:30 amRNSBoard Change
12th Oct 201812:07 pmRNSSecond Price Monitoring Extn
12th Oct 201812:02 pmRNSPrice Monitoring Extension
10th Oct 201812:07 pmRNSSecond Price Monitoring Extn
10th Oct 201812:02 pmRNSPrice Monitoring Extension
8th Oct 201812:07 pmRNSSecond Price Monitoring Extn
8th Oct 201812:02 pmRNSPrice Monitoring Extension
2nd Oct 20185:30 pmRNSDirector/PDMR Shareholding
2nd Oct 20187:00 amRNSTrading Update
1st Oct 20184:51 pmRNSTotal Voting Rights
7th Sep 20184:35 pmRNSPrice Monitoring Extension
3rd Sep 20184:18 pmRNSDirector/PDMR Shareholding
3rd Sep 20188:58 amRNSHolding(s) in Company
23rd Aug 20184:19 pmRNSDirector/PDMR Shareholding
20th Aug 20181:41 pmRNSDirector/PDMR Shareholding
8th Aug 20184:00 pmRNSHolding(s) in Company
10th Jul 20184:52 pmRNSHolding(s) in Company
9th Jul 20183:32 pmRNSDirector/PDMR Shareholding
5th Jul 201812:11 pmRNSHolding(s) in Company
4th Jul 201812:08 pmRNSTotal Voting Rights
13th Jun 201810:14 amRNSDirector/PDMR Shareholding
11th Jun 20184:47 pmRNSHolding(s) in Company
8th Jun 20187:00 amRNSBlock Listing Application
5th Jun 201812:07 pmRNSBlock Listing Six Monthly Return - Replacement
4th Jun 20185:00 pmRNSHolding(s) in Company
4th Jun 201810:42 amRNSBlock Listing Six Monthly Return
1st Jun 201811:30 amRNSTotal Voting Rights
1st Jun 201811:24 amRNSHolding(s) in Company
31st May 20183:50 pmRNSCompletion of disposal
18th May 201811:13 amRNSDirector/PDMR Shareholding
11th May 20184:50 pmRNSDirector/PDMR Shareholding
8th May 20187:19 amRNSHalf-year Report
8th May 20187:15 amRNSDisposal
30th Apr 201812:20 pmRNSTotal Voting Rights and Capital
27th Apr 20184:39 pmRNSHolding(s) in Company
11th Apr 20183:56 pmRNSHolding(s) in Company
6th Apr 20181:31 pmRNSHolding(s) in Company
5th Apr 20187:00 amRNSTrading Update
26th Mar 20184:41 pmRNSDirector/PDMR Shareholding
26th Mar 20184:41 pmRNSDirector/PDMR Shareholding
5th Mar 20183:03 pmRNSDirector/PDMR Shareholding
8th Feb 20183:08 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.